Translated mutation in the Nurr1 gene as a cause for Parkinson's disease
Identifieur interne : 002762 ( Main/Exploration ); précédent : 002761; suivant : 002763Translated mutation in the Nurr1 gene as a cause for Parkinson's disease
Auteurs : David A. Grimes [Canada] ; Fabin Han [Canada] ; Michel Panisset [Canada] ; Lemuel Racacho [Canada] ; Fengxia Xiao [Canada] ; Ruobing Zou [Canada] ; Kelly Westaff [Canada] ; Dennis E. Bulman [Canada]Source :
- [ 0885-3185 ]
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Amino Acid Substitution (genetics), Chromatography, High Pressure Liquid, Cysteine (genetics), DNA Mutational Analysis, DNA-Binding Proteins (genetics), Exons, Female, Heterozygote Detection, Humans, Introns, Male, Middle Aged, Mutation, Nervous system diseases, Nuclear Receptor Subfamily 4, Group A, Member 2, Parkinson Disease (genetics), Parkinson disease, Polymorphism, Genetic (genetics), Protein Biosynthesis (genetics), Sequence Analysis, Serine (genetics), Transcription Factors (genetics).
- MESH :
- chemical , genetics : Cysteine, DNA-Binding Proteins, Serine, Transcription Factors.
- genetics : Amino Acid Substitution, Parkinson Disease, Polymorphism, Genetic, Protein Biosynthesis.
- Aged, Chromatography, High Pressure Liquid, DNA Mutational Analysis, Exons, Female, Heterozygote Detection, Humans, Introns, Male, Middle Aged, Nuclear Receptor Subfamily 4, Group A, Member 2, Sequence Analysis.
Abstract
Multiple genes have been now identified as causing Parkinson's disease (PD). In 2003, two mutations were identified in exon 1 of the Nurr1 gene in 10 of 107 individuals with familial PD. To date, investigators have only focused on screening for these known mutations of the Nurr1 gene. All individuals were recruited from two Parkinson's disease clinics in Canada. Following PCR amplification of each exon of the Nurr1 gene, samples underwent denaturing high‐performance liquid chromatography (DHPLC) analysis. Ten individuals also underwent direct sequencing as well as any samples where variants were identified. The Nurr1 gene was evaluated for 202 PD individuals, 37% of whom had at least one relative with PD and 100 control non‐PD individuals. Using DHPLC and direct sequencing, we did not detect any sequence variants in exon 1. Variants in amplicon 6 were seen and direct sequencing confirmed a known NI6P polymorphism in intron 6. Novel polymorphisms were also identified in exon 3 and intron 5. A novel mutation was identified in exon 3 in one nonfamilial PD individual. This heterozygous C‐to‐G transversion resulted in a serine‐to‐cysteine substitution and was not identified in any of the other 602 chromosomes screened. Mutations in the Nurr1 gene in our large cohort of familial and sporadic PD individuals are rare. The novel mutation in exon 3 is predicted to affect phosphorylation and functional studies to assess this are underway. This is the first coding mutation identified in the Nurr1 gene for Parkinson's disease. © 2006 Movement Disorder Society
Url:
DOI: 10.1002/mds.20820
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000025
- to stream Istex, to step Curation: 000025
- to stream Istex, to step Checkpoint: 000B03
- to stream PubMed, to step Corpus: 001158
- to stream PubMed, to step Curation: 001158
- to stream PubMed, to step Checkpoint: 001158
- to stream Ncbi, to step Merge: 000627
- to stream Ncbi, to step Curation: 000627
- to stream Ncbi, to step Checkpoint: 000627
- to stream Main, to step Merge: 002A49
- to stream PascalFrancis, to step Corpus: 000814
- to stream PascalFrancis, to step Curation: 000509
- to stream PascalFrancis, to step Checkpoint: 000684
- to stream Main, to step Merge: 002B82
- to stream Main, to step Curation: 002762
Le document en format XML
<record><TEI wicri:istexFullTextTei="no"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Translated mutation in the Nurr1 gene as a cause for Parkinson's disease</title><author><name sortKey="Grimes, David A" sort="Grimes, David A" uniqKey="Grimes D" first="David A." last="Grimes">David A. Grimes</name></author><author><name sortKey="Han, Fabin" sort="Han, Fabin" uniqKey="Han F" first="Fabin" last="Han">Fabin Han</name></author><author><name sortKey="Panisset, Michel" sort="Panisset, Michel" uniqKey="Panisset M" first="Michel" last="Panisset">Michel Panisset</name></author><author><name sortKey="Racacho, Lemuel" sort="Racacho, Lemuel" uniqKey="Racacho L" first="Lemuel" last="Racacho">Lemuel Racacho</name></author><author><name sortKey="Xiao, Fengxia" sort="Xiao, Fengxia" uniqKey="Xiao F" first="Fengxia" last="Xiao">Fengxia Xiao</name></author><author><name sortKey="Zou, Ruobing" sort="Zou, Ruobing" uniqKey="Zou R" first="Ruobing" last="Zou">Ruobing Zou</name></author><author><name sortKey="Westaff, Kelly" sort="Westaff, Kelly" uniqKey="Westaff K" first="Kelly" last="Westaff">Kelly Westaff</name></author><author><name sortKey="Bulman, Dennis E" sort="Bulman, Dennis E" uniqKey="Bulman D" first="Dennis E." last="Bulman">Dennis E. Bulman</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:01B6640287AFDB5B2E7D59B6CC17ABE7138EF9ED</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1002/mds.20820</idno><idno type="url">https://api-v5.istex.fr/document/01B6640287AFDB5B2E7D59B6CC17ABE7138EF9ED/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000025</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000025</idno><idno type="wicri:Area/Istex/Curation">000025</idno><idno type="wicri:Area/Istex/Checkpoint">000B03</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000B03</idno><idno type="wicri:doubleKey">0885-3185:2006:Grimes D:translated:mutation:in</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:16532445</idno><idno type="wicri:Area/PubMed/Corpus">001158</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001158</idno><idno type="wicri:Area/PubMed/Curation">001158</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001158</idno><idno type="wicri:Area/PubMed/Checkpoint">001158</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001158</idno><idno type="wicri:Area/Ncbi/Merge">000627</idno><idno type="wicri:Area/Ncbi/Curation">000627</idno><idno type="wicri:Area/Ncbi/Checkpoint">000627</idno><idno type="wicri:doubleKey">0885-3185:2006:Grimes D:translated:mutation:in</idno><idno type="wicri:Area/Main/Merge">002A49</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:06-0393849</idno><idno type="wicri:Area/PascalFrancis/Corpus">000814</idno><idno type="wicri:Area/PascalFrancis/Curation">000509</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000684</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000684</idno><idno type="wicri:doubleKey">0885-3185:2006:Grimes D:translated:mutation:in</idno><idno type="wicri:Area/Main/Merge">002B82</idno><idno type="wicri:Area/Main/Curation">002762</idno><idno type="wicri:Area/Main/Exploration">002762</idno></publicationStmt><sourceDesc><biblStruct><analytic><author><name sortKey="Grimes, David A" sort="Grimes, David A" uniqKey="Grimes D" first="David A." last="Grimes">David A. Grimes</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Medicine, Division of Neurology, Ottawa Hospital, Ottawa, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Ottawa Health Research Institute, University of Ottawa, Centre for Neuromuscular Disease, Ottawa, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Ottawa Hospital, Civic Campus, 1053 Carling Avenue, Ottawa, K1Y 4E9</wicri:regionArea><wicri:noRegion>K1Y 4E9</wicri:noRegion></affiliation></author><author><name sortKey="Han, Fabin" sort="Han, Fabin" uniqKey="Han F" first="Fabin" last="Han">Fabin Han</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Ottawa Health Research Institute, University of Ottawa, Centre for Neuromuscular Disease, Ottawa, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Panisset, Michel" sort="Panisset, Michel" uniqKey="Panisset M" first="Michel" last="Panisset">Michel Panisset</name><affiliation wicri:level="4"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Neurology, McGill Centre for Studies in Aging, McGill University, Montreal, Quebec</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Racacho, Lemuel" sort="Racacho, Lemuel" uniqKey="Racacho L" first="Lemuel" last="Racacho">Lemuel Racacho</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Ottawa Health Research Institute, University of Ottawa, Centre for Neuromuscular Disease, Ottawa, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Xiao, Fengxia" sort="Xiao, Fengxia" uniqKey="Xiao F" first="Fengxia" last="Xiao">Fengxia Xiao</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Ottawa Health Research Institute, University of Ottawa, Centre for Neuromuscular Disease, Ottawa, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Zou, Ruobing" sort="Zou, Ruobing" uniqKey="Zou R" first="Ruobing" last="Zou">Ruobing Zou</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Ottawa Health Research Institute, University of Ottawa, Centre for Neuromuscular Disease, Ottawa, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Westaff, Kelly" sort="Westaff, Kelly" uniqKey="Westaff K" first="Kelly" last="Westaff">Kelly Westaff</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Ottawa Health Research Institute, University of Ottawa, Centre for Neuromuscular Disease, Ottawa, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Bulman, Dennis E" sort="Bulman, Dennis E" uniqKey="Bulman D" first="Dennis E." last="Bulman">Dennis E. Bulman</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Medicine, Division of Neurology, Ottawa Hospital, Ottawa, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Ottawa Health Research Institute, University of Ottawa, Centre for Neuromuscular Disease, Ottawa, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author></analytic><series><idno type="ISSN">0885-3185</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Amino Acid Substitution (genetics)</term><term>Chromatography, High Pressure Liquid</term><term>Cysteine (genetics)</term><term>DNA Mutational Analysis</term><term>DNA-Binding Proteins (genetics)</term><term>Exons</term><term>Female</term><term>Heterozygote Detection</term><term>Humans</term><term>Introns</term><term>Male</term><term>Middle Aged</term><term>Mutation</term><term>Nervous system diseases</term><term>Nuclear Receptor Subfamily 4, Group A, Member 2</term><term>Parkinson Disease (genetics)</term><term>Parkinson disease</term><term>Polymorphism, Genetic (genetics)</term><term>Protein Biosynthesis (genetics)</term><term>Sequence Analysis</term><term>Serine (genetics)</term><term>Transcription Factors (genetics)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Cysteine</term><term>DNA-Binding Proteins</term><term>Serine</term><term>Transcription Factors</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Amino Acid Substitution</term><term>Parkinson Disease</term><term>Polymorphism, Genetic</term><term>Protein Biosynthesis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Chromatography, High Pressure Liquid</term><term>DNA Mutational Analysis</term><term>Exons</term><term>Female</term><term>Heterozygote Detection</term><term>Humans</term><term>Introns</term><term>Male</term><term>Middle Aged</term><term>Nuclear Receptor Subfamily 4, Group A, Member 2</term><term>Sequence Analysis</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Mutation</term><term>Parkinson maladie</term><term>Système nerveux pathologie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Multiple genes have been now identified as causing Parkinson's disease (PD). In 2003, two mutations were identified in exon 1 of the Nurr1 gene in 10 of 107 individuals with familial PD. To date, investigators have only focused on screening for these known mutations of the Nurr1 gene. All individuals were recruited from two Parkinson's disease clinics in Canada. Following PCR amplification of each exon of the Nurr1 gene, samples underwent denaturing high‐performance liquid chromatography (DHPLC) analysis. Ten individuals also underwent direct sequencing as well as any samples where variants were identified. The Nurr1 gene was evaluated for 202 PD individuals, 37% of whom had at least one relative with PD and 100 control non‐PD individuals. Using DHPLC and direct sequencing, we did not detect any sequence variants in exon 1. Variants in amplicon 6 were seen and direct sequencing confirmed a known NI6P polymorphism in intron 6. Novel polymorphisms were also identified in exon 3 and intron 5. A novel mutation was identified in exon 3 in one nonfamilial PD individual. This heterozygous C‐to‐G transversion resulted in a serine‐to‐cysteine substitution and was not identified in any of the other 602 chromosomes screened. Mutations in the Nurr1 gene in our large cohort of familial and sporadic PD individuals are rare. The novel mutation in exon 3 is predicted to affect phosphorylation and functional studies to assess this are underway. This is the first coding mutation identified in the Nurr1 gene for Parkinson's disease. © 2006 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Canada</li></country><region><li>Québec</li></region><settlement><li>Montréal</li></settlement><orgName><li>Université McGill</li></orgName></list><tree><country name="Canada"><noRegion><name sortKey="Grimes, David A" sort="Grimes, David A" uniqKey="Grimes D" first="David A." last="Grimes">David A. Grimes</name></noRegion><name sortKey="Bulman, Dennis E" sort="Bulman, Dennis E" uniqKey="Bulman D" first="Dennis E." last="Bulman">Dennis E. Bulman</name><name sortKey="Bulman, Dennis E" sort="Bulman, Dennis E" uniqKey="Bulman D" first="Dennis E." last="Bulman">Dennis E. Bulman</name><name sortKey="Grimes, David A" sort="Grimes, David A" uniqKey="Grimes D" first="David A." last="Grimes">David A. Grimes</name><name sortKey="Grimes, David A" sort="Grimes, David A" uniqKey="Grimes D" first="David A." last="Grimes">David A. Grimes</name><name sortKey="Han, Fabin" sort="Han, Fabin" uniqKey="Han F" first="Fabin" last="Han">Fabin Han</name><name sortKey="Panisset, Michel" sort="Panisset, Michel" uniqKey="Panisset M" first="Michel" last="Panisset">Michel Panisset</name><name sortKey="Racacho, Lemuel" sort="Racacho, Lemuel" uniqKey="Racacho L" first="Lemuel" last="Racacho">Lemuel Racacho</name><name sortKey="Westaff, Kelly" sort="Westaff, Kelly" uniqKey="Westaff K" first="Kelly" last="Westaff">Kelly Westaff</name><name sortKey="Xiao, Fengxia" sort="Xiao, Fengxia" uniqKey="Xiao F" first="Fengxia" last="Xiao">Fengxia Xiao</name><name sortKey="Zou, Ruobing" sort="Zou, Ruobing" uniqKey="Zou R" first="Ruobing" last="Zou">Ruobing Zou</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002762 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002762 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:01B6640287AFDB5B2E7D59B6CC17ABE7138EF9ED
|texte= Translated mutation in the Nurr1 gene as a cause for Parkinson's disease
}}
| This area was generated with Dilib version V0.6.29. |  |